205 related articles for article (PubMed ID: 20166126)
1. Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.
Heemers HV; Schmidt LJ; Kidd E; Raclaw KA; Regan KM; Tindall DJ
Prostate; 2010 Jun; 70(9):959-70. PubMed ID: 20166126
[TBL] [Abstract][Full Text] [Related]
2. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM
BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762
[TBL] [Abstract][Full Text] [Related]
3. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM
J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916
[TBL] [Abstract][Full Text] [Related]
4. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP
Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.
Lai KP; Huang CK; Chang YJ; Chung CY; Yamashita S; Li L; Lee SO; Yeh S; Chang C
Am J Pathol; 2013 Feb; 182(2):460-73. PubMed ID: 23219429
[TBL] [Abstract][Full Text] [Related]
6. Expression of androgen receptor coregulators in prostate cancer.
Linja MJ; Porkka KP; Kang Z; Savinainen KJ; Jänne OA; Tammela TL; Vessella RL; Palvimo JJ; Visakorpi T
Clin Cancer Res; 2004 Feb; 10(3):1032-40. PubMed ID: 14871982
[TBL] [Abstract][Full Text] [Related]
7. Androgen modulation of coregulator expression in prostate cancer cells.
Heemers HV; Regan KM; Schmidt LJ; Anderson SK; Ballman KV; Tindall DJ
Mol Endocrinol; 2009 Apr; 23(4):572-83. PubMed ID: 19164447
[TBL] [Abstract][Full Text] [Related]
8. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.
Wang C; Sun H; Zou R; Zhou T; Wang S; Sun S; Tong C; Luo H; Li Y; Li Z; Wang E; Chen Y; Cao L; Li F; Zhao Y
Nucleic Acids Res; 2015 May; 43(10):4893-908. PubMed ID: 25934801
[TBL] [Abstract][Full Text] [Related]
9. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF.
Yu C; Gong AY; Chen D; Solelo Leon D; Young CY; Chen XM
Mol Nutr Food Res; 2013 Oct; 57(10):1825-33. PubMed ID: 23661605
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of PinX1 in prostate cancer cells through androgen receptor dependent and independent mechanisms.
Flores-Ramírez I; Rivas-Torres MÁ; Rodríguez-Dorantes M; Gutiérrez-Sagal R; Baranda-Avila N; Langley E
J Steroid Biochem Mol Biol; 2021 Jun; 210():105858. PubMed ID: 33647521
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
12. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
[TBL] [Abstract][Full Text] [Related]
13. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
[TBL] [Abstract][Full Text] [Related]
14. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu CL; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C
J Biol Chem; 2004 Aug; 279(32):33438-46. PubMed ID: 15166229
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor cofactors: A potential role in understanding prostate cancer.
Li X; Xiong H; Mou X; Huang C; Thomas ER; Yu W; Jiang Y; Chen Y
Biomed Pharmacother; 2024 Apr; 173():116338. PubMed ID: 38417290
[TBL] [Abstract][Full Text] [Related]
16. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
[TBL] [Abstract][Full Text] [Related]
17. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
Bennett NC; Hooper JD; Johnson DW; Gobe GC
Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
[TBL] [Abstract][Full Text] [Related]
19. Different expression of androgen receptor coactivators in human prostate.
Fujimoto N; Mizokami A; Harada S; Matsumoto T
Urology; 2001 Aug; 58(2):289-94. PubMed ID: 11489729
[TBL] [Abstract][Full Text] [Related]
20. Androgen regulation of the androgen receptor coregulators.
Urbanucci A; Waltering KK; Suikki HE; Helenius MA; Visakorpi T
BMC Cancer; 2008 Aug; 8():219. PubMed ID: 18673534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]